Harbour BioMed Appoints Dr. Ian Y. Liu as Global Head of Legal
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and ...
Morningstar8d
Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 12, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and ...
The Manila Times9d
Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 11, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...
Hypebeast24d
Rotterdam’s FENIX Museum is Set to Open in May
Netherlands, the FENIX museum is inspired by the stories of global migration. Spanning 16,000 square meters, the large building is set to open in a landmark location in Rotterdam’s city harbor.
Medindia8d
Harbour BioMed Launches lanc Therapeutics to Advance Next-Generation Obesity Therapies
Harnessing Harbour BioMed's proprietary HCAb-based bispecific antibody technology, �lanc� aims to develop innovative therapies addressing key challenges in current obesity treatment, including muscle ...
Morningstar9d
Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and ...